{
  "ticker": "ABBV",
  "last_updated": "2025-04-19T07:36:40.944791",
  "retention_years": 3,
  "count": 111,
  "transactions": [
    {
      "id": 44009,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Alpern Robert J",
      "reporting_owner_cik": "0001448074",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "34443"
    },
    {
      "id": 44011,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "FREYMAN THOMAS C",
      "reporting_owner_cik": "0001239126",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "125548"
    },
    {
      "id": 44018,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "MEYER MELODY B",
      "reporting_owner_cik": "0001706126",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "15295"
    },
    {
      "id": 44019,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hart Brett J",
      "reporting_owner_cik": "0001466338",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18269"
    },
    {
      "id": 44020,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RAPP EDWARD J",
      "reporting_owner_cik": "0001171780",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "31356"
    },
    {
      "id": 44023,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37255"
    },
    {
      "id": 44030,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Davis Jennifer L.",
      "reporting_owner_cik": "0001916665",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1322"
    },
    {
      "id": 44034,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "TILTON GLENN F",
      "reporting_owner_cik": "0001194624",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "50361"
    },
    {
      "id": 44043,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Roberts Rebecca B",
      "reporting_owner_cik": "0001355580",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12525"
    },
    {
      "id": 44044,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "BURNSIDE WILLIAM H.L.",
      "reporting_owner_cik": "0001563579",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "25755"
    },
    {
      "id": 44045,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "WADDELL FREDERICK H",
      "reporting_owner_cik": "0001223690",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "27755"
    },
    {
      "id": 44050,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Quaggin Susan E",
      "reporting_owner_cik": "0001997505",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-03",
      "transaction_shares": "1322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1322"
    },
    {
      "id": 14329,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-03-20",
      "transaction_shares": "21082",
      "transaction_price": "176.30",
      "transaction_type": "S",
      "shares_after_transaction": "55903"
    },
    {
      "id": 27190,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-03-20",
      "transaction_shares": "21082",
      "transaction_price": "176.30",
      "transaction_type": "S",
      "shares_after_transaction": "55903"
    },
    {
      "id": 44022,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-03-20",
      "transaction_shares": "21082",
      "transaction_price": "176.30",
      "transaction_type": "S",
      "shares_after_transaction": "55903"
    },
    {
      "id": 14326,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-03-18",
      "transaction_shares": "26110",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "119890"
    },
    {
      "id": 27184,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-03-18",
      "transaction_shares": "26110",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "119890"
    },
    {
      "id": 44013,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-03-18",
      "transaction_shares": "26110",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "119890"
    },
    {
      "id": 14339,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-03-01",
      "transaction_shares": "45700",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "89517"
    },
    {
      "id": 27200,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-03-01",
      "transaction_shares": "45700",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "89517"
    },
    {
      "id": 44035,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-03-01",
      "transaction_shares": "45700",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "89517"
    },
    {
      "id": 14324,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-28",
      "transaction_shares": "20634",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "107267"
    },
    {
      "id": 14328,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-28",
      "transaction_shares": "4914",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "23259"
    },
    {
      "id": 14331,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "5339",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "13872"
    },
    {
      "id": 14333,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "16771",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "76985"
    },
    {
      "id": 14337,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "37638",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "145964"
    },
    {
      "id": 14345,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-28",
      "transaction_shares": "7885",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "20288"
    },
    {
      "id": 14347,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23847",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "43817"
    },
    {
      "id": 14348,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "26121",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "93780"
    },
    {
      "id": 14349,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-28",
      "transaction_shares": "110249",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "657715"
    },
    {
      "id": 14351,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23966",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "219978"
    },
    {
      "id": 27182,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-28",
      "transaction_shares": "20634",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "107267"
    },
    {
      "id": 27188,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-28",
      "transaction_shares": "4914",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "23259"
    },
    {
      "id": 27192,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "5339",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "13872"
    },
    {
      "id": 27194,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "16771",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "76985"
    },
    {
      "id": 27198,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "37638",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "145964"
    },
    {
      "id": 27206,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-28",
      "transaction_shares": "7885",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "20288"
    },
    {
      "id": 27208,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23847",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "43817"
    },
    {
      "id": 27209,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "26121",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "93780"
    },
    {
      "id": 27210,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-28",
      "transaction_shares": "110249",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "657715"
    },
    {
      "id": 27212,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23966",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "219978"
    },
    {
      "id": 44010,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-28",
      "transaction_shares": "20634",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "107267"
    },
    {
      "id": 44017,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-28",
      "transaction_shares": "4914",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "23259"
    },
    {
      "id": 44025,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "5339",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "13872"
    },
    {
      "id": 44027,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "16771",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "76985"
    },
    {
      "id": 44032,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "37638",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "145964"
    },
    {
      "id": 44041,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-28",
      "transaction_shares": "7885",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "20288"
    },
    {
      "id": 44046,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23847",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "43817"
    },
    {
      "id": 44047,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "26121",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "93780"
    },
    {
      "id": 44048,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-28",
      "transaction_shares": "110249",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "657715"
    },
    {
      "id": 44051,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-28",
      "transaction_shares": "23966",
      "transaction_price": "178.99",
      "transaction_type": "F",
      "shares_after_transaction": "219978"
    },
    {
      "id": 14342,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-27",
      "transaction_shares": "1670",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "770489"
    },
    {
      "id": 27203,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-27",
      "transaction_shares": "1670",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "770489"
    },
    {
      "id": 44038,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-27",
      "transaction_shares": "1670",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "770489"
    },
    {
      "id": 14330,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-23",
      "transaction_shares": "14140",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "41205"
    },
    {
      "id": 14346,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "31092"
    },
    {
      "id": 27191,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-23",
      "transaction_shares": "14140",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "41205"
    },
    {
      "id": 27207,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "31092"
    },
    {
      "id": 44024,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-23",
      "transaction_shares": "14140",
      "transaction_price": "61.36",
      "transaction_type": "M",
      "shares_after_transaction": "41205"
    },
    {
      "id": 44042,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "M",
      "shares_after_transaction": "31092"
    },
    {
      "id": 14327,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-21",
      "transaction_shares": "52870",
      "transaction_price": "58.88",
      "transaction_type": "M",
      "shares_after_transaction": "296814"
    },
    {
      "id": 27185,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-21",
      "transaction_shares": "52870",
      "transaction_price": "58.88",
      "transaction_type": "M",
      "shares_after_transaction": "296814"
    },
    {
      "id": 44014,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-21",
      "transaction_shares": "52870",
      "transaction_price": "58.88",
      "transaction_type": "M",
      "shares_after_transaction": "296814"
    },
    {
      "id": 4499,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 4500,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 4501,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 4502,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 4503,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 4504,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 4506,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 4507,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 4508,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 4509,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 4510,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 14323,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 14325,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 14332,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 14334,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 14335,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 14336,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 14340,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 14341,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 14343,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 14344,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 14350,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 27181,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 27183,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 27193,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 27195,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 27196,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 27197,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 27201,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 27202,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 27204,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 27205,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 27211,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 44008,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Thakkar Roopal",
      "reporting_owner_cik": "0002004979",
      "reporting_owner_position": "SVP, CMO, GLOBAL THERAPEUTICS",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 44012,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-15",
      "transaction_shares": "8022",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "18399"
    },
    {
      "id": 44026,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "45934"
    },
    {
      "id": 44028,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "146335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "669629"
    },
    {
      "id": 44029,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, CHIEF OPERATIONS OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "32097",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "221946"
    },
    {
      "id": 44031,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, CSO, GLOBAL RESEARCH",
      "transaction_date": "2024-02-15",
      "transaction_shares": "28322",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "109651"
    },
    {
      "id": 44036,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Donoghoe Nicholas",
      "reporting_owner_cik": "0001762951",
      "reporting_owner_position": "EVP, CHIEF BUS/STRAT OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "22657",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "78560"
    },
    {
      "id": 44037,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Buckbee Kevin K",
      "reporting_owner_cik": "0001968528",
      "reporting_owner_position": "SVP, CONTROLLER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "7080",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "14243"
    },
    {
      "id": 44039,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "11800",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12609"
    },
    {
      "id": 44040,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "PRES & CHIEF OPERATING OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "49565",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "148210"
    },
    {
      "id": 44049,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2024-02-15",
      "transaction_shares": "33042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93983"
    },
    {
      "id": 4505,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    },
    {
      "id": 14338,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    },
    {
      "id": 27199,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    },
    {
      "id": 44033,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2024-02-02",
      "transaction_shares": "2919",
      "transaction_price": "144.54",
      "transaction_type": "A",
      "shares_after_transaction": "13296"
    }
  ]
}